Half-year report 2024

Consolidated statement of changes in equity

January 1 – June 30

 

 

 

 

Attributable to shareholders of medmix Ltd

 

 

 

 

millions of CHF

 

Notes

 

Share capital

 

Retained earnings

 

Treasury shares

 

Cash flow hedge reserve

 

Currency translation adjustment

 

Total

 

Non-controlling interests

 

Total equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity as of January 1, 2023

 

 

 

0.4

 

540.3

 

–12.5

 

0.7

 

–24.1

 

504.8

 

 

504.8

Comprehensive income for the period:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

7.3

 

 

 

 

 

 

 

7.3

 

 

7.3

– Cash flow hedges, net of tax

 

 

 

 

 

 

0.6

 

 

0.6

 

 

0.6

– Remeasurements of defined benefit plans, net of tax

 

 

 

 

–0.3

 

 

 

 

–0.3

 

 

–0.3

– Currency translation differences

 

 

 

 

–3.2

 

–3.2

 

 

–3.2

Other comprehensive income

 

 

 

 

–0.3

 

 

0.6

 

–3.2

 

–2.9

 

 

–2.9

Total comprehensive income for the period

 

 

 

 

7.0

 

 

0.6

 

–3.2

 

4.4

 

 

4.4

Sale of investments in subsidiaries

 

 

 

 

–1.7

 

 

 

 

–1.7

 

 

–1.7

Contribution to the Sulzer group

 

8

 

 

–0.3

 

 

 

 

–0.3

 

 

–0.3

Transactions with owners of the company:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allocation of treasury shares to share plan participants

 

8

 

 

–0.4

 

0.4

 

 

 

 

 

Purchase of treasury shares

 

8

 

 

 

–1.0

 

 

 

–1.0

 

 

–1.0

Share-based payments

 

 

 

 

1.1

 

 

 

 

1.1

 

 

1.1

Dividends

 

8

 

 

–20.5

 

 

 

 

–20.5

 

 

–20.5

Equity as of June 30, 2023

 

 

 

0.4

 

525.7

 

–13.1

 

1.3

 

–27.3

 

486.9

 

 

486.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity as of January 1, 2024

 

 

 

0.4

 

529.8

 

–15.2

 

–0.9

 

–48.7

 

465.4

 

9.0

 

474.3

Comprehensive income for the period:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

5.2

 

 

 

 

 

 

 

5.2

 

0.4

 

5.6

– Cash flow hedges, net of tax

 

 

 

 

 

 

–2.6

 

 

–2.6

 

 

–2.6

– Remeasurements of defined benefit plans, net of tax

 

 

 

 

0.9

 

 

 

 

0.9

 

 

0.9

– Currency translation differences

 

 

 

 

15.6

 

15.6

 

0.4

 

16.0

Other comprehensive income

 

 

 

 

0.9

 

 

–2.6

 

15.6

 

13.9

 

0.4

 

14.3

Total comprehensive income for the period

 

 

 

 

6.1

 

 

–2.6

 

15.6

 

19.1

 

0.8

 

19.9

Sale of investments in subsidiaries

 

 

 

 

–0.2

 

 

 

 

–0.2

 

 

–0.2

Put option liability

 

8

 

 

–3.2

 

 

 

 

–3.2

 

 

–3.2

Contribution to the Sulzer group

 

8

 

 

–0.1

 

 

 

 

–0.1

 

 

–0.1

Transactions with owners of the company:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allocation of treasury shares to share plan participants

 

8

 

 

–1.1

 

1.1

 

 

 

 

 

Purchase of treasury shares

 

8

 

 

 

–0.5

 

 

 

–0.5

 

 

–0.5

Share-based payments

 

 

 

 

0.8

 

 

 

 

0.8

 

 

0.8

Dividends

 

8

 

 

–20.4

 

 

 

 

–20.4

 

 

–20.4

Equity as of June 30, 2024

 

 

 

0.4

 

511.6

 

–14.6

 

–3.6

 

–33.0

 

460.8

 

9.8

 

470.6